Plasminogen activator inhibitor-1
Plasminogen Activator Inhibitor-1 (PAI-1)[edit | edit source]
Plasminogen Activator Inhibitor-1 (PAI-1) is a protein that plays a crucial role in the regulation of the fibrinolysis system. It is a member of the serpin (serine protease inhibitor) superfamily and is the principal inhibitor of the plasminogen activators, tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA). PAI-1 is encoded by the SERPINE1 gene in humans.
Function[edit | edit source]
PAI-1 is primarily involved in the inhibition of fibrinolysis, the process that prevents blood clots from growing and becoming problematic. By inhibiting tPA and uPA, PAI-1 controls the conversion of plasminogen to plasmin, the enzyme responsible for breaking down fibrin clots. This regulation is essential for maintaining the balance between clot formation and dissolution, which is critical for normal hemostasis.
Regulation[edit | edit source]
The activity of PAI-1 is regulated at multiple levels, including transcriptional, post-transcriptional, and post-translational modifications. Factors such as cytokines, hormones, and growth factors can influence PAI-1 expression. Additionally, PAI-1 activity is modulated by its interaction with other proteins, such as vitronectin, which stabilizes PAI-1 in its active form.
Clinical Significance[edit | edit source]
Elevated levels of PAI-1 are associated with an increased risk of thrombosis, as excessive inhibition of fibrinolysis can lead to the persistence of blood clots. This condition is linked to various cardiovascular diseases, including myocardial infarction and stroke. Conversely, PAI-1 deficiency can lead to a bleeding tendency due to excessive fibrinolysis.
PAI-1 is also implicated in metabolic syndrome, obesity, and insulin resistance. It is considered a marker of inflammation and is involved in the pathophysiology of fibrosis and cancer metastasis.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
